Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1729 News Items found Vik Gill: The Uplifter Friday, May 6, 2022 Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants. FDA Approves Immunotherapy That’s Less Intensive for People With Lymphoma Thursday, May 5, 2022 In April 2022, the FDA approved the immunotherapy drug axicabtagene ciloleucel (Yescarta®) for the treatment of diffuse large B cell lymphoma earlier in the course of disease. Retired teacher and basketball coach Joe Crimi is one of the patients who benefited from this treatment. ‘People Want To Be Heard’: Meet MSK’s New Chief Nurse, Tracy Gosselin Thursday, May 5, 2022 Memorial Sloan Kettering's new chief nurse Tracy Gosselin says she was taken by surprise when she was asked to consider MSK's top nursing job. Cannabis and Cancer: What We Know So Far Wednesday, May 4, 2022 Dr. Diane Reidy-Lagunes discusses cannabis and cancer with MSK’s Director of Pediatric Integrated Medicine, Dr. Nirupa Raghunathan, and cancer survivor and winner of TV’s “Survivor: Africa”, Ethan Zohn. How To Talk to Family and Friends About a Cancer Diagnosis Linked to HPV Tuesday, May 3, 2022 An MSK expert gives advice on how to talk to family and friends about a cancer diagnosis linked to HPV, which some people find particularly challenging. In the Lab New Immunotherapy Approach Targets a Commonly Mutated ‘Driver’ Protein Unique to Cancer Cells Friday, April 29, 2022 Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer. SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy Wednesday, April 20, 2022 The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies. With CryoEM, MSK Researchers Obtain Exquisite View of the Androgen Receptor — A Key Protein in Prostate Cancer Wednesday, April 20, 2022 The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins. Memorial Sloan Kettering Cancer Center Receives $12M in Grants on Break Through Cancer’s One Year Anniversary Tuesday, April 19, 2022 The collective efforts of the “TeamLabs” will accelerate discoveries in glioblastoma, ovarian, and pancreatic cancers Q&A What Every Man Should Know about Radiation Therapy for Prostate Cancer Tuesday, April 19, 2022 It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer